| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 02/27/2003 | WO2003016272A2 Improving bioavailability of carbapewem salts by nanofiltration |
| 02/27/2003 | WO2002100862A3 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 02/27/2003 | WO2002092602A3 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE |
| 02/27/2003 | WO2002064590A3 Carboline derivatives |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/26/2003 | CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 02/26/2003 | CN1399636A Adenosine receptor antagonists and methods of making and using the same |
| 02/25/2003 | US6525075 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene |
| 02/20/2003 | WO2002100858A3 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 02/20/2003 | WO2002098427A3 Sustained-release analgesic compounds |
| 02/20/2003 | US20030036652 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines |
| 02/20/2003 | US20030036547 And preparation from yohimbic acid and an alkylene (especially an oxyalkylene) diamine |
| 02/19/2003 | EP1119571B1 Tricyclic delta3-piperidines as alpha2-antagonists |
| 02/19/2003 | EP0981530B1 Compounds on the basis of polyalkyl-1-oxa-diazaspirodecane compounds |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2002088146A3 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/12/2003 | EP0980374B1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/12/2003 | EP0937078B1 Tricyclic carbapenem compounds |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/11/2003 | US6518423 Benzopiperidine derivatives |
| 02/11/2003 | US6518263 Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 02/06/2003 | WO2002059123A3 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
| 02/06/2003 | WO2002039953A3 Texaphyrin coordination compounds and uses thereof |
| 02/06/2003 | US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer |
| 02/06/2003 | US20030027809 1-hydroxyethyl-2(imidazo(5,1b)thiazol-2-yl-1-carbapen-2-em-3-c carboxylic acid or salt, excellent antibiotic activity against a wide spectrum of bacteria |
| 02/05/2003 | EP1281711A1 Interstrand crosslinking agents for dna and compounds therefor |
| 02/05/2003 | EP1280805A1 Novel imidazotriazinones and the use thereof |
| 02/05/2003 | EP1280530A1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 02/05/2003 | CN1101008C Electrophotographic photoconductor and method for producing the same |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 01/30/2003 | WO2003008422A1 Chemical compounds |
| 01/30/2003 | WO2002057271A3 Thienopyrimidine-based inhibitors of the src family |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | US20030022890 Heterocyclic dihydropyrimidine compounds |
| 01/30/2003 | US20030022883 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 01/30/2003 | US20030022881 Novel carbapenem derivatives of quarternary salt type |
| 01/30/2003 | US20030022876 Sustained-release analgesic compounds |
| 01/29/2003 | EP1278750A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 01/28/2003 | US6511987 Heterocyclic derivatives that bind to the benzodiazepine site of GABAA receptors for treatment of central nervous system disorders |
| 01/23/2003 | WO2003006468A2 Polymerisable charge transport compounds |
| 01/23/2003 | WO2002088143A3 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 01/23/2003 | US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease |
| 01/22/2003 | CN1392875A Condensed azepines as vasopressino agonists |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/16/2003 | WO2003004503A1 Morpholine-bridged pyrazolopyridine derivatives |
| 01/16/2003 | WO2003004496A1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013028 Crystalline reaction product having charge generating properties of a phenylenebis(dicyanopyrazine) and a phthalonitrile or a diiminoisoindole which may be metallized |
| 01/16/2003 | CA2452590A1 Morpholine-bridged pyrazolopyridine derivatives |
| 01/15/2003 | EP1275652A2 Mono-, oligo- and polydithienopyridines and their use as charge transport materials |
| 01/15/2003 | CN1391574A Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition |
| 01/14/2003 | US6506772 Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. |
| 01/14/2003 | US6506768 Tetrahydro γ-carbolines |
| 01/09/2003 | WO2003002064A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | WO2003001887A2 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | WO2002076397A3 Telomerase inhibitors and methods of their use |
| 01/09/2003 | WO2002064594A3 6-substituted pyrido-pyrimidines |
| 01/09/2003 | US20030008893 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation |
| 01/09/2003 | US20030008863 Novel tricyclic diazepines tocolytic oxytocin receptor antagonists |
| 01/09/2003 | US20030008304 Fluorescent quenching detection reagents and methods |
| 01/09/2003 | CA2451840A1 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | CA2451800A1 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/08/2003 | CN1390217A Bicyclic and tricyclic heteroaromatic compounds |
| 01/07/2003 | US6503914 Thienopyrimidine-based inhibitors of the Src family |
| 01/07/2003 | CA2252813C 3- and 3,8-substituted 1,10-phenanthrolines and their use in electron and energy transfer processes |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2002002563A3 Substituted-triazolopyrimidines as anticancer agents |
| 01/02/2003 | EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 01/01/2003 | CN1388120A Intermediate used as new industrial products in preparation of new cephalosporin containing sbstituted benzyloxy imino on 7-position |
| 12/31/2002 | CA2064112C .alpha.-dihydroergocryptine pharmaceutical preparations with neuroprotective activity |
| 12/27/2002 | WO2002104072A2 Emissive multichromophoric systems |
| 12/27/2002 | WO2002009758A3 Inhibitors of cellular efflux pumps of microbes |
| 12/27/2002 | WO2001085095B1 Chiral fluoroquinolizinone arginine salt forms |
| 12/27/2002 | CA2439060A1 Emissive multichromophoric systems |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof |
| 12/24/2002 | CA2252402C Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 12/19/2002 | WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 12/19/2002 | WO2002100858A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/19/2002 | WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 12/19/2002 | WO2002088144A3 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE |
| 12/19/2002 | US20020193366 Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists |
| 12/19/2002 | US20020193365 Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-HT1A antagonists |
| 12/19/2002 | CA2445471A1 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotic acetylcholine receptors |
| 12/19/2002 | CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 12/18/2002 | EP1023062B1 Antibacterial carbapenems, compositions and methods of treatment |
| 12/17/2002 | US6495559 For therapy of obesity |
| 12/17/2002 | US6495555 Tricyclic Δ-3-piperidines as α2-antagonists |
| 12/17/2002 | US6495541 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 12/12/2002 | WO2002099141A1 Fluorescent quenching detection reagents and methods |
| 12/12/2002 | WO2002098875A1 Carboline derivatives as pde-5 inhibitors |